As the battle to combat the spread of COVID-19 wages on nationwide, the team at Temple Health and Bioscience District (THBD) collaborates with innovators across Central Texas to ensure public health and safety. This August, a new tool was introduced in Temple, Texas to help identify the virus and mitigate risks.
While many other developers and manufacturers focus on diagnostic testing to identify the virus in patients, Industrial Genetics, a startup company at THBD, has developed a way to identify the virus that causes COVID-19 (SARS-CoV-2) in wastewater and on surfaces.
“Industrial Genetics was created to help provide clarity amidst uncertain times,” says Founder and President David Sprague, Ph.D. “The first step to winning the war against COVID-19 is to determine where the outbreaks are taking place before the effects of COVID-19 have taken hold. Our diagnostic testing is the ideal way to see if there is a problem at your organization by determining the amount of virus in your wastewater and on surfaces. By providing evidence-based understanding of SARS-CoV-2 and the pandemic, our customers can then proceed confidently to identifying the correct solution.”
This advancement allows businesses and organizations to obtain more data on COVID-19 risks in high-traffic areas, which is particularly important as schools reopen this fall. In addition to schools, healthcare providers, office settings, and essential businesses all have a tremendous need to understand the risk of contracting COVID-19 within their environments and among colleagues and staff.
All of the testing will be conducted locally at the Temple Health and Bioscience District (THBD). This 5,000 sq. ft office and laboratory facility consists of seven tenant offices, three tenant labs, 700 sq. ft of common lab space, administrative offices, two conference rooms, and a break room. Industrial Genetics is part of the THBD incubator which boasts an impressive array of equipment designed to help researchers like Dr. Sprague launch innovative technologies to improve public health.
“We are so proud of the work that Dr. Sprague and his team are conducting,” says THBD Executive Director Tami Annable. “As we all search for answers amid the pandemic, Industrial Genetics is taking the next steps to ensure safer work, school, and medical environments.”
To inquire about surface or wastewater testing for your organization and for more information, visit IndustrialGeneticsLLC.com.
With the advent of new technologies like Industrial Genetics’ testing, THBD continues to attract startups and small businesses looking to make waves in Central Texas’ thriving life science ecosystem. To learn more about the incubator, visit templebioscience.org.